Blog - Page 3274 of 5571

ThursdayAug 11, 2011 11:11 am

Cord Blood America Inc. (CBAI) Posts First Half 2011 Results

Cord Blood America Inc. is the parent of CorCell, which facilitates umbilical cord blood stem cell preservation. Cord blood stem cells offer a potentially life-saving resource for treating a growing number of ailments including cancer, leukemia, blood and immune disorders. The company today announced its financial results for the first half of 2011. It reported revenues of $2.89 million for the first six months of 2011, up 61% compared to revenues of $1.79 million in the same period in 2010. Revenues for the second quarter ended June 30, 2011 totaled $1.43 million, up 50% compared to 2010's second quarter revenues…

ThursdayAug 11, 2011 10:33 am

Canadian Solar Inc. (CSIQ) to Supply Solar Modules to New Solar Plant

Today, one of the world’s largest solar companies, Canadian Solar Inc., announced that it will supply 8 MW of solar modules to EOSOL Energies Nouvelles' new ground-mounted solar power plant, which will have an installed capacity of 10.7 MW. The new solar power plant will be located in Saint-Leger in the south west of France with a total of 39,500 modules installed on an area of 180,000 m². The company anticipates that it will activate the new solar power plant in October 2011. EOSOL EN previously selected Canadian Solar's high-quality, high-performance solar modules for three earlier installations in France: a…

ThursdayAug 11, 2011 10:11 am

Imperial Petroleum, Inc. (IPMN) Engages Wolfe Axelrod Weinberger Associates for Investor Relations Services

Shortly after today’s opening bell, Imperial Petroleum announced that it has retained Wolfe Axelrod Weinberger Associates LLC as its investor relations firm to communicate the company’s strategic goals and business developments to the investment community. Mr. Jeffrey T. Wilson, CEO of Imperial Petroleum, noted, "Imperial has reached an inflection point in its growth that warrants an active investor relations program. After a careful search and review, we have selected Wolfe Axelrod Weinberger Associates to assist us in our investor relations efforts because of its focus on emerging microcap companies and its extensive contacts among investors who are interested in new,…

WednesdayAug 10, 2011 4:20 pm

Ever-Glory International (EVK) Posts Solid Q2 Results, Continued Positive Outlook for Q3

Ever-Glory International Group Inc., a leading apparel supply chain manager and retailer based in China, today reported its financial results for the second quarter ended June 30, 2011, reflecting increased sales in its retail and wholesale businesses. During the second quarter of 2011, Ever-Glory reported an 85 percent increase in net sales to $42.9 million compared to $23.1 million in the second quarter of 2010. Second quarter net income was $2.3 million, or $0.15 per diluted share, an increase of 182.1 percent from $0.8 million, or $0.05 per diluted share, in the second quarter of 2010. Second quarter 2011 gross…

WednesdayAug 10, 2011 3:19 pm

Bohai Pharmaceuticals Group, Inc. (BOPH) Expands Presence in Chinese TCM Market with Acquisition of Yantai Tianzheng

Bohai Pharmaceuticals Group, Inc., a Chinese pharmaceuticals company engaged in the production, manufacturing and distribution of modernized herbal products based on Traditional Chinese Medicine (TCM), announced today that it has made the acquisition of a complimentary TCM company in China. The all cash acquisition of 100% of the outstanding shares of Yantai Tianzheng significantly expands Bohai's standing in the TCM market by adding products, manufacturing and sales capabilities. The transaction, consisting of four installment payments over 18 months for a total of $35 million, includes a stipulation that Jinghoo Chi, Yantai Tianzheng's majority owner and CEO, will remain with Bohai…

WednesdayAug 10, 2011 3:09 pm

Access Pharmaceuticals, Inc. (ACCP) Expands Reach with CSPN

Access Pharmaceuticals, Inc. yesterday announced that Community Specialty Pharmacy Network has joined its specialty pharmacy network for the MuGard product. MuGard is a new product being produced by Access for oral mucositis. Houston, Texas-based Access Pharmaceuticals is a biopharmaceutical that focuses on developing and marketing a series of proprietary products for the care of cancer patients. The company's product line includes MuGard, ProLindac (for treating ovarian cancer) and Thirabine (a new nucleoside). Access also produces the CobaCyte and CobOral drug delivery systems. CSPN has more than 180 member pharmacies and offers a range of services, including mail distribution, therapy management,…

WednesdayAug 10, 2011 2:07 pm

Royal Financial, Inc. (RYFL) Terminates Employee Stock Ownership Plan

Royal Financial, Inc. and Royal Savings Bank, a wholly owned subsidiary of the Company, announced the end to their employee stock ownership plan (ESOP). According to Royal CEO Leonard Szwajkowski, the company "determined that the benefits of the ESOP were not sufficient to justify the ongoing annual expense incurred to maintain the plan. The costs savings we will achieve in future periods will more than compensate for the one-time charges incurred to terminate the ESOP.” Company estimates of savings due to the change range from $40,000 to $45,000 per year. The cost of terminating the ESOP plan, says the company,…

WednesdayAug 10, 2011 1:58 pm

Toreador Resources Corp. (TRGL) and ZaZa Energy, LLC to Merge

Toreador Resources Corp. and ZaZa Energy, LLC announced late Tuesday night the execution of a definitive agreement to merge the pair into a single enterprise, with Toreador bringing its oil holdings and ZaZa coming in with its oil and gas portfolio. Based on Toreador stock’s Tuesday close, the implied market capitalization for the new company is about $294 million. Rodman & Renshaw, LLC is serving as financial advisor to Houston-based ZaZa in the deal, while RBC Capital Markets is serving as financial advisor to Toreador. The new company will assume the name ZaZa Energy Corporation. Under the merger terms, though…

WednesdayAug 10, 2011 1:50 pm

Genesis Biopharma, Inc. (GNBP) Signs CRADA with the National Crisis Institute for the Development of Cancer Immunotherapies

Genesis Biopharma, Inc., a biopharmaceutical company that engages in the development and commercialization of drugs and other clinical solutions for underserved diseases, announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI). Under the terms of the five-year development and cooperative research agreement, Genesis Biopharma will be working with Steven A. Rosenburg, M.D., Ph.D., the NCI Surgery Branch Chief, in order to develop adoptive cell immunotherapies that are created to destroy metastatic melanoma cells utilizing a patient’s tumor infiltrating lymphocytes. More specifically, the CRADA will (i) provide support to the in…

WednesdayAug 10, 2011 1:16 pm

Beacon Equity Research Featured Company: Orofino Gold Corp. (ORFG)

Orofino Gold Corp. is a Colombia-based gold producer focused on discovering, acquiring and expanding mineral-rich resource deposits. The company was founded in 2009 by former executives and management with over 50 years of combined mining exploration, finance, and development experience. The company currently operates mines in the Senderos de Oro area of Colombia, nearby Ventana Gold Corp’s proven La Bodega asset and Greystar Resources Ltd’s Angostura project. Orofino also has rights to other lands in the gold-producing region totaling over 3,000 hectares as well as an option on a portfolio of other small producers and development/exploration assets. Orofino aims to…

Site Search

Company Search